Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Jinheng Pharmaceutical is a pharmaceutical manufacturing company based in Dunhua, Jilin Province, China, specializing in the development and production of traditional Chinese medicines (TCM) and chemical pharmaceuticals. The company maintains multiple GMP-certified production lines for dosage forms including capsules, tablets, granules, and oral liquids. Its product portfolio focuses on therapeutic areas such as cardiovascular health, gastroenterology, and respiratory medicine, utilizing both synthetic chemistry and natural medicinal resources from the Changbai Mountain region. Jinheng is recognized as a high-tech enterprise and has historically been listed on the National Equities Exchange and Quotations (NEEQ) in China. The company's business model encompasses the entire value chain from R&D and raw material extraction to large-scale manufacturing and commercial distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Jinheng Pharmaceutical.